companydata.dkcompanydata.dk

JANSSEN-CILAG A/S: Financial statements 2023

CVR: 19248615

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

JANSSEN-CILAG A/S (CVR 19248615) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 1,430,113,000 and a net result of DKK 45,041,000 compared with DKK 59,772,000 the year before. That is a decrease of 2.7% compared with the year before. The profit margin was 3.1%. Equity in the 2023 report amounted to DKK 158,776,000. The solvency ratio was 29.3%. The company had 127 employees in the financial year.

Revenue
DKK 1,430,113,000
Gross Profit
DKK 290,374,000
Profit/Loss
DKK 45,041,000
Equity
DKK 158,776,000
Total Assets
DKK 541,811,000
Employees
127

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20231.4B290.4M45M158.8M127
20221.5B309.4M59.8M163.7M135
20211.3B286.1M60.6M135M142
20201.3B270.4M56.4M132.8M116
20191.2B273.7M54.8M126.4M115

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

JANSSEN-CILAG A/S wins public contractDec 1, 2023

JANSSEN-CILAG A/S has won the tender "Rammeaftale om Knæimplantater" issued by Region Midtjylland worth 103,335,186 DKK.

JANSSEN-CILAG A/S wins public contractNov 24, 2023

JANSSEN-CILAG A/S has won the tender "Udbud af rygkirurgi - genudbud af delkontrakt 1 og 2" issued by Region Midtjylland worth 77,582,964 DKK.

JANSSEN-CILAG A/S: The 2022 annual report is outJul 3, 2023

JANSSEN-CILAG A/S has published its annual report for 2022. Revenue came to DKK 1,469,932,000, and the net result was DKK 59,772,000.

Emil Wellington Suenson joins the board of JANSSEN-CILAG A/SJun 27, 2023

As of June 27, 2023, Emil Wellington Suenson has joined the board of directors of JANSSEN-CILAG A/S.

Adam Markku Pentas leaves the board of JANSSEN-CILAG A/SJun 27, 2023

As of June 27, 2023, Adam Markku Pentas has left the board of directors of JANSSEN-CILAG A/S.

Julie Enevold Brooker joins the board of JANSSEN-CILAG A/SMay 1, 2023

As of May 1, 2023, Julie Enevold Brooker has joined the board of directors of JANSSEN-CILAG A/S.

Adam Markku Pentas joins the board of JANSSEN-CILAG A/SMay 1, 2023

As of May 1, 2023, Adam Markku Pentas has joined the board of directors of JANSSEN-CILAG A/S.

Duarte Joao Lourinho Marchand joins the board of JANSSEN-CILAG A/SMay 1, 2023

As of May 1, 2023, Duarte Joao Lourinho Marchand has joined the board of directors of JANSSEN-CILAG A/S.

Sven Kragelund Dohmann leaves the board of JANSSEN-CILAG A/SMay 1, 2023

As of May 1, 2023, Sven Kragelund Dohmann has left the board of directors of JANSSEN-CILAG A/S.

Duarte Joao Lourinho Marchand joins JANSSEN-CILAG A/S as directorMay 1, 2023

As of May 1, 2023, Duarte Joao Lourinho Marchand is registered as director of JANSSEN-CILAG A/S.

About JANSSEN-CILAG A/S

JANSSEN-CILAG A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JANSSENPHARMA A/S. The management consists of Mario Klesse. The board consists of Philipp Christian Hellweg (chair), Liana Akhmetzhanova, Mario Klesse and Nevret Mahmudovski. The company is owned by Janssen Cilag AB. The company has 116 employees (2026). In 2025, the company reported revenue of DKK 1,442,304,000 and a net result of DKK 43,183,000 compared with DKK 64,466,000 the year before. Equity in the 2025 report amounted to DKK 216,425,000.

Source: annual report 2025, Danish Business Authority